News
-
-
COMMUNIQUÉ DE PRESSE
Galloper Gold Corp. Announces Listing and Trading of Its Common Shares on the Canadian Securities Exchange
Galloper Gold Corp. announces approval for listing on the Canadian Securities Exchange effective March 1, 2024, under symbol 'BOOM'. Details on shares, warrants, and escrow restrictions disclosed -
-
COMMUNIQUÉ DE PRESSE
Wild Bill's Olde Fashioned Soda Co. Partners With Bazooka Candy Brands to Unveil Nostalgic Limited Edition Ring Pop Flavors
Wild Bill's & Ring Pop's limited-edition craft sodas in Blue Raspberry and Berry Blast transport consumers to sweet childhood memories. Collaboration with Bazooka Candy Brands introduces nostalgic flavors -
-
COMMUNIQUÉ DE PRESSE
Beyond the Illusion: Ever Dreamed of Escaping the Matrix? Dive Into Dr. Isaac J. Sun's New Book 'The Earth's Matrix: The Code of Human Life'
Explore a new perspective on freedom & connection with 'The Earth's Matrix: The Code of Human Life'. Discover how to harmonize with the complexities of life on Earth -
-
COMMUNIQUÉ DE PRESSE
enVVeno Medical Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
enVVeno Medical Corporation reports $46.4 million in cash, progress towards the VenoValve U.S. pivotal trial, and financial results for 2023, anticipating value driving milestones in 2024 -
-
COMMUNIQUÉ DE PRESSE
Sonnet BioTherapeutics Announces a Publication Demonstrating Safety and Tolerability of SON-1010 in Healthy Volunteers
Sonnet BioTherapeutics Holdings, Inc. announced the publication of clinical data on SON-1010, a tumor-targeted immunotherapeutic drug combining FHAB construct with IL-12 in Frontiers in Immunology, showing favorable safety and tolerability
